| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Corresponding author: Nara Figueroa-Bossi, Centre de Génétique Moléculaire, CNRS, 91198 Gif-sur-Yvette Cedex, France., figueroa{at}cgm.cnrs-gif.fr (E-mail)
Communicating editor: G. R. SMITH
| ABSTRACT |
|---|
A class of gyrase mutants of Salmonella enterica mimics the properties of bacteria exposed to quinolones. These mutants suffer spontaneous DNA breakage during normal growth and depend on recombinational repair for viability. Unlike quinolone-treated bacteria, however, they do not show accumulation of cleavable gyrase-DNA complexes. In recA or recB mutant backgrounds, the temperature-sensitive (ts) allele gyrA208 causes rapid cell death at 43°. Here, we isolated "suppressor-of-death" mutations, that is, secondary changes that allow a gyrA208 recB double mutant to survive a prolonged exposure to 43° and subsequently to form colonies at 28°. In most isolates, the secondary change was itself a ts mutation. Three ts alleles were mapped in genes coding for amino acyl tRNA synthetases (alaS, glnS, and lysS). Allele alaS216 completely abolished DNA breakage in a gyrA208 recA double mutant. Likewise, treating this mutant with chloramphenicol prevented death and DNA damage at 43°. Additional suppressors of gyrA208 lethality include rpoB mutations and, surprisingly, icd mutations inactivating isocitrate dehydrogenase. We postulate that the primary effect of the gyrase alteration is to hamper replication fork movement. Inhibiting DNA replication under conditions of continuing macromolecular synthesis ("unbalanced growth") activates a mechanism that causes DNA breakage and cell death, reminiscent of "thymineless" lethality.
TYPE II DNA topoisomerases are enzymes that can change the linking number of DNA by a mechanism involving transient double-strand cleavage and passage of a separate segment of the DNA molecule through the cut site (reviewed in ![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
Bacterial type II topoisomerases are the targets of a family of antibacterial agents of clinical relevance: the quinolone antibiotics and their derivatives (reviewed in ![]()
![]()
![]()
Several lines of evidence point to the involvement of DNA replication in this event. An in vitro study showed that the collision between a moving replication fork and a stalled topoisomerase can convert the complex to a nonreversible form (![]()
![]()
![]()
![]()
![]()
![]()
![]()
In a previous study, we described a peculiar class of DNA gyrase mutants of Salmonella that mimics the response of wild-type bacteria to quinolone treatment (![]()
![]()
| MATERIALS AND METHODS |
|---|
Bacteria and phage:
All strains used in this study are derivatives of Salmonella enterica serovar Typhimurium strain LT2. These strains are listed in Table 1 except for those carrying suppressor mutations that remain uncharacterized and the strains of the Mud-P22 mapping kit (![]()
![]()
![]()
|
Plasmids:
Plasmid pTAC875N carries the Escherichia coli alaS gene under the control of the Tac promoter (![]()
![]()
![]()
Media and growth conditions:
Bacteria were cultured at 28° or 37° in liquid media or in media solidified with 1.5% (w/v) Difco agar. Difco nutrient broth (NB; 0.8% w/v) supplemented with NaCl (0.5% w/v) or Luria-Bertani (LB) broth (![]()
![]()
![]()
Cytological methods:
For visualization of nucleoid morphology, bacteria were stained with 4',6-diamino-2-phenyl-indole (DAPI) and examined through a fluorescence microscope (Reichert-Jung) as previously described (![]()
Isolation and characterization of suppressors of gyrA208 lethality:
Cultures of strain MA2383 (gyrA208
[recB] din-1001::MudJ) were grown at 28° in LB to stationary phase. A sample of 0.1 ml from each culture (
108 bacteria) was spread on LB plates, incubated for 24 hr at 43°, and then shifted to 28° and incubated for an additional 48 hr. Survivors occurred at a frequency of 50100 cfu/plate. Independent isolates were picked and initially screened for the ability to grow at 37° and 43°. Rare revertants of the gyrA208 mutation were readily identified from their ability to form large white colonies at 43° and were discarded. The remaining isolates could be separated into two classes: those still incapable of growing at 37° (class A, representing the majority of isolates) and those that grew at this temperature (class B). Next, the suppressor mutations were transferred to a wild-type genetic background. This was achieved in three steps: (i) rendering the strains RecB+ (by transduction, selecting Arg+); (ii) isolating Tn10- dTc insertions near each of the suppressor loci: a phage P22 lysate made on a pool of random Tn10dTc transposition mutants was used to transduce the suppressor-harboring strains to Tc resistance scoring for the loss of suppression (in the presence of din1001::MudJ, unsuppressed gyrA208 causes bacteria to form wrinkled blue colonies on X-gal indicator plates at 37°); and (iii) backcrossing the insertions so obtained into the suppressor background and transductionally transferring the suppressor mutations into a wild-type strain selecting Tc resistance. The tentative map location of the suppressor gene or of the nearby Tn10dTc element was determined using the Mud-P22 lysogen collection of ![]()
|
DNA labeling:
Chromosomal DNA was uniformly labeled by growing cells in the presence of [3H]thymine as previously described (![]()
| RESULTS |
|---|
Mutation gyrA208 causes cell filamentation and death:
Our previous work showed that some phenotypic traits associated with a particular class of gyrase mutations in Salmonella do not result from DNA supercoiling defects. This was most evident with the highly lethal gyrA208 allele, which affects negative supercoiling levels only marginally (![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
|
|
Strains carrying gyrA208 in combination with either recA or recB mutations rapidly die when incubated at 43° (Fig 3). The rate of killing is more dramatic if bacteria are incubated on solid medium (conditions under which even a recombination-proficient gyrA208 mutant suffers a marked loss of viability following overnight incubation; data not shown). This suggests that one might gather insight into the cytocidal mechanism from the analysis of mutations that suppressed death at 43°.
|
Suppressors of gyrA208-mediated cell death:
Aminoacyl tRNA synthetase mutations:
We searched for suppressor mutations in strain MA2383, which harbors gyrA208 and a nonrevertable recB deletion. The selection protocol involved incubating bacteria spread on LB plates (lawns of 108 cells) for 24 hr at 43° and then shifting the plates back to 28° to allow surviving cells to form colonies. Except for rare revertants of the gyrA208 mutation (readily identified and discarded; see MATERIALS AND METHODS), all of the isolates that were obtained behaved as expected for "suppressor-of-death" mutations: they did not grow at 43° but experienced little or no loss of viability during prolonged incubation at this temperature (data not shown). It soon became apparent that the majority of these "death suppressors" resulted from mutations that by themselvesi.e., in a gyr+ genetic backgroundconferred a temperature-sensitive growth phenotype. Genetic mapping and complementation tests identified three such suppressors (s-43, s-57, s-41) as mutant alleles of alanine, glutamine, and lysine tRNA synthetases, respectively. The ability of these mutations to suppress the lethal phenotype correlates with their property to cause cytostasis at the restrictive temperature (Fig 4). Because the primary consequence of aminoacyl tRNA synthetase defects is the inhibition of protein synthesis, we tested whether chloramphenicol, a protein synthesis inhibitor, would also suppress killing of a gyrA208 recB mutant at 43°. Treatment with this drug (20 µg/ml) effectively prevented death of the mutant at the restrictive temperature (data not shown). Inhibition of protein synthesis, by drug or mutation, also relieved the loss of viability suffered by a recombination-proficient gyrA208 mutant when subjected to a prolonged exposure to 43° on solid medium (data not shown).
|
Icd mutations:
A class of mutations resulting from the suppression-of-death selection above did not confer a ts phenotype. Strains carrying this class of suppressors appeared to require glutamate or proline to grow in minimal medium, were incapable of using acetate as the sole carbon source, and grew slowly in all media, including LB. These characteristics, as well as genetic mapping, allowed us to identify the auxotrophic mutations as alleles of the icd gene encoding isocitrate dehydrogenase. Repeating the suppressor-of-death search by transposon mutagenesis, we were able to obtain Tn10dTc insertion mutants of the icd gene. Significantly, icd mutants were originally obtained in E. coli during a search for bacteria resistant to nalidixic acid (![]()
![]()
![]()
RNA polymerase mutations:
Earlier, we described a class of RNA polymerase (rpoB) mutations conferring low-level resistance to nalidixic acid in Salmonella (![]()
Induction of the stringent response can contribute to gyrA208 suppression:
In enteric bacteria, the synthesis of cell envelope constituents, such as peptidoglycan and membrane phospholipids, is negatively controlled by guanosine 3',5'-bis(diphosphate) (ppGpp), the mediator of the stringent response (reviewed in ![]()
![]()
![]()
We studied the effects of a spoT mutation on gyrA208 lethality. The spoT1 allele greatly increased survival of the gyrA208 mutant at 43° (strain MA3170). As expected, this effect was completely eliminated by the subsequent introduction of a relA mutation (in strain MA3382; data not shown). Unexpectedly, the relA1 mutation also inhibited gyrA208 suppression in the glnS1521 and lysS103 aminoacyl tRNA synthetase mutants, whereas suppression by alaS216 remained unaffected (Table 3). Closer examination revealed that the differential sensitivity to the relA mutation correlates with the degree of "leakiness" of the synthetase alleles. While alaS216 brings bacterial growth to a sudden and complete arrest at 43°, glnS1521 and lysS1031 both show a leaky phenotype, allowing bacterial cells to continue dividing at a slow pace (data not shown). In conclusion, these results show that the induction of the stringent response (elicited by poor tRNA aminoacylation) critically contributes to gyrA208 suppression in the glnS and lysS mutants (Table 3; note that the three synthetase mutations suppress gyrA208 lethality with approximately the same efficiency in a relA+ background). No such contribution is needed when protein synthesis is completely inhibited.
|
Inhibition of protein synthesis prevents "reckless" DNA degradation in gyrA208 recA1 mutant:
Formation of DNA breaks in bacteria defective in RecA activity leads to extensive DNA degradation. This results from the "reckless" activity of the ExoV nuclease (RecBCD) that uses double-strand DNA ends as entry sites (![]()
![]()
![]()
In this study, we sought to determine whether mutations or treatments suppressing gyrA208 recA lethality concomitantly blocked degradation. Results in Fig 5 show that DNA degradation no longer occurs following the introduction of the alaS216 allele (strain MA4122) or upon treating cells with chloramphenicol during the 43° incubation. Since the strains used for these experiments are devoid of detectable recombinational activity, it seems unlikely that these results could be explained by postulating that the inhibition of protein synthesis simply allows more time for DNA lesions to be repaired. Rather, the most likely conclusion is that the gyrase-mediated lesions are no longer formed when protein synthesis is inhibited or, more generally, when bacterial growth is arrested.
|
| DISCUSSION |
|---|
The gyrA208 allele is representative of a class of gyrase alterations that have little effect on DNA supercoiling but cause lethality by inducing chromosomal breakage. Under conditions of inadequate recombinational repair, these mutations lead to irreversible DNA damage and cell death. In this study we sought to gather insight into the mechanism of killing through the isolation of second-site suppressors preventing death at the restrictive temperature (43°). Three such suppressors were found to result from aminoacyl tRNA synthetase changes that either block or strongly slow growth at 43°. In the synthetase mutants that still grow at 43°, suppression of gyrA208 lethality depends on the activity of the relA gene product, suggesting that induction of the stringent responseconsequent to poor tRNA amino-acylationcontributes to suppression. In turn, this suggests that the mechanism of killing is in relation to some aspect(s) of cell development rather than to protein synthesis per se. Consistent with this interpretation, suppression of death can also result from accumulation of a growth-inhibitory Krebs cycle intermediate consequent to the inactivation of iso-citrate dehydrogenase.
The changes or conditions that suppress gyrA208 lethality are the same as those that protect bacteria against killing by quinolones. This was already evident in previous studies in which mutations affecting RNA or protein synthesis were isolated by selecting for low-level resistance to Nal and found to suppress gyrA208 (![]()
![]()
At first glance, the gyrA208 mutation could act in a drug-like manner causing the gyrase reaction to stall at the stage of the cleavable complex. However, we found no evidence for a spontaneous accumulation of cleavable complexes in the gyrA208 mutant under any condition tested (![]()
![]()
In both the gyrA208 mutant and Nal-treated bacteria, DNA breakage occurs in dividing cells, suggesting that the mechanism responsible for damage is connected with cell growth. This dependence is strongly reminiscent of the phenomenon known as "thymineless" death, the rapid killing of thymine auxotrophic microorganisms in response to thymine starvation (reviewed by ![]()
![]()
![]()
![]()
![]()
![]()
| FOOTNOTES |
|---|
1 Present address: Departament de Ciències Mèdiques Bàsiques, Universitat de Lleida, 25006 Lleida, Spain. ![]()
| ACKNOWLEDGMENTS |
|---|
We are grateful to Montserrat Llagostera and John Roth for providing strains and to Philippe Bouloc, Pierre Plateau, and Jacqueline Plumbridge for the generous gift of plasmids. We thank Amando Flores for first identifying the icd mutants and contributing to their characterization. E.G. was the recipient of a fellowship from the Human Capital and Mobility Program of the European Community Commission. This work was supported by the Centre National de la Recherche Scientifique.
Manuscript received May 4, 2001; Accepted for publication September 7, 2001.
| LITERATURE CITED |
|---|
AHMAD, S. I., S. H. KIRK, and A. EISENSTARK, 1998 Thymine metabolism and thymineless death in prokaryotes and eukaryotes. Annu. Rev. Microbiol. 52:591-625[Medline].
BARNER, H. D. and S. S. COHEN, 1957 The isolation and properties of amino acid requiring mutants of a thymineless bacterium. J. Bacteriol. 74:350-355
BENSON, N. R. and B. S. GOLDMAN, 1992 Rapid mapping in Salmonella typhimurium with Mud-P22 prophages. J. Bacteriol. 174:1673-1681
BERGER, J. M., 1998 Type II DNA topoisomerases. Curr. Opin. Struct. Biol. 8:26-32[Medline].
BLANC-POTARD, A.-B. and L. BOSSI, 1994 Phenotypic suppression of DNA gyrase deficiencies by a deletion lowering the gene dosage of a major tRNA in Salmonella typhimurium.. J. Bacteriol. 176:2216-2226
BLANC-POTARD, A.-B., E. GARÍ, F. SPIRITO, N. FIGUEROA-BOSSI, and L. BOSSI, 1995 RNA polymerase (rpoB) mutants selected for resistance to gyrase inhibitors in S. typhimurium. Mol. Gen. Genet. 247:680-692[Medline].
CASHEL, M., D. R. GENTRY, V. J. HERNANDEZ and D. VINELLA, 1996 The stringent response, pp. 14581496 in Escherichia coli and Salmonella: Cellular and Molecular Biology, Ed. 2, edited by F. C. NEIDHARDT, R. CURTISS, III, J. L. INGRAHAM, E. C. C. LIN, K. B. LOW, B. MAGASANIK, W. S. REZNIKOFF, M. RILEY, M. SCHAECHTER and H. E. UMBARGER. American Society for Microbiology, Washington, DC.
CHEN, C. R., M. MALIK, M. SNYDER, and K. DRLICA, 1996 DNA gyrase and topoisomerase IV on the bacterial chromosome: quinolone-induced DNA cleavage. J. Mol. Biol. 258:627-637[Medline].
CLERCH, B., X. GARRIGA, E. TORRENTS, C. M. ROSALES, and M. LLAGOSTERA, 1996 Construction and characterization of two lexA mutants of Salmonella typhimurium with different UV sensitivities and UV mutabilities. J. Bacteriol. 178:2890-2896
DEITZ, W. H., T. M. COOK, and W. A. GOSS, 1966 Mechanism of action of nalidixic acid on Escherichia coli. III. Conditions required for lethality. J. Bacteriol. 91:768-773
DONACHIE, W. D. and K. J. BEGG, 1989 Cell length, nucleoid separation, and cell division of rod-shaped and spherical cells of Escherichia coli. J. Bacteriol. 171:4633-4639
DRLICA, K. and X. ZHAO, 1997 DNA gyrase, topoisomerase IV, and the 4-quinolones. Microbiol. Mol. Biol. Rev. 61:377-392[Abstract].
EL HANAFI, D. and L. BOSSI, 2000 Activation and silencing of leu-500 promoter by transcription-induced DNA supercoiling in the Salmonella chromosome. Mol. Microbiol. 37:583-594[Medline].
FIGUEROA-BOSSI, N., E. COISSAC, P. NETTER, and L. BOSSI, 1997 Unsuspected prophage-like elements in Salmonella typhimurium. Mol. Microbiol. 25:161-173[Medline].
GARÍ, E., N. FIGUEROA-BOSSI, A.-B. BLANC-POTARD, F. SPIRITO, and M. B. SCHMID et al., 1996 A class of gyrase mutants of Salmonella typhimurium show quinolone-like lethality and require Rec functions for viability. Mol. Microbiol. 21:111-122[Medline].
HANAWALT, P. C., O. MAALØE, D. J. CUMMINGS, and M. SCHAECHTER, 1961 The normal DNA replication cycle. II. J. Mol. Biol. 3:156-165[Medline].
HEDDLE, J. G., F. M. BARNARD, L. M. WENTZELL, and A. MAXWELL, 2000 The interaction of drugs with DNA gyrase: a model for the molecular basis of quinolone action. Nucleosides Nucleotides Nucleic Acids 19:1249-1264[Medline].
HELLING, R. B. and J. S. KUKORA, 1971 Nalidixic acid-resistant mutants of Escherichia coli deficient in isocitrate dehydrogenase. J. Bacteriol. 105:1224-1226
HIASA, H., D. O. YOUSEF, and K. J. MARIANS, 1996 DNA strand cleavage is required for replication fork arrest by a frozen topoisomerase-quinolone-DNA ternary complex. J. Biol. Chem. 271:26424-26429
HUSSAIN, K., E. J. ELLIOTT, and G. P. SALMOND, 1987 The parD- mutant of Escherichia coli also carries a gyrAam mutation. The complete sequence of gyrA. Mol. Microbiol. 1:259-273[Medline].
KAMPRANIS, S. C., A. D. BATES, and A. MAXWELL, 1999 A model for the mechanism of strand passage by DNA gyrase. Proc. Natl. Acad. Sci. USA 96:8414-8419
KATO, J., Y. NISHIMURA, and H. SUZUKI, 1989 Escherichia coli parA is an allele of the gyrB gene. Mol. Gen. Genet. 217:178-181[Medline].
KHODURSKY, A. B., B. J. PETER, M. B. SCHMID, J. DERISI, and D. BOTSTEIN et al., 2000 Analysis of topoisomerase function in bacterial replication fork movement: use of DNA microarrays. Proc. Natl. Acad. Sci. USA 97:9419-9424
KOHNO, T. and J. R. ROTH, 1974 Proflavin mutagenesis of bacteria. J. Mol. Biol. 89:17-32[Medline].
LAKSHMI, T. M. and R. B. HELLING, 1976 Selection for citrate synthase deficiency in icd mutants of Escherichia coli. J. Bacteriol. 127:76-83
LEVEQUE, F., P. PLATEAU, P. DESSEN, and S. BLANQUET, 1990 Homology of lysS and lysU, the two Escherichia coli genes encoding distinct lysyl-tRNA synthetase species. Nucleic Acids Res. 18:305-312
LEVINE, C., H. HIASA, and K. J. MARIANS, 1998 DNA gyrase and topoisomerase IV: biochemical activities, physiological roles during chromosome replication, and drug sensitivities. Biochim. Biophys. Acta 1400:29-43[Medline].
LIU, L. F., 1989 DNA topoisomerase poisons as antitumor drugs. Annu. Rev. Biochem. 58:351-375[Medline].
LIU, L and J. C. WANG, 1987 Supercoiling of the DNA template during transcription. Proc. Natl. Acad. Sci. USA 84:7024-7027
MAALØE, O. and P. C. HANAWALT, 1961 Thymine deficiency and the normal DNA replication cycle II. J. Mol. Biol. 3:144-155[Medline].
MALOY, S. R., W. J. STEWART and R. K. TAYLOR, 1996 Genetic Analysis of Pathogenic Bacteria. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
MENZEL, R. and M. GELLERT, 1994 The biochemistry and biology of DNA gyrase. Adv. Pharmacol. 29:39-69.
MIESEL, L. and J. R. ROTH, 1994 Salmonella recD mutations increase recombination in a short sequence transduction assay. J. Bacteriol. 176:4092-4103
MUKHERJEE, A., C. CAO, and J. LUTKENHAUS, 1998 Inhibition of FtsZ polymerization by SulA, an inhibitor of septation in Escherichia coli.. Proc. Natl. Acad. Sci. USA 95:2885-2890
PLUMBRIDGE, J., 1987 Organisation of the Escherichia coli chromosome between genes glnS and glnU, V. Mol. Gen. Genet. 209:618-620[Medline].
RUDD, K. E., B. R. BOCHNER, M. CASHEL, and J. R. ROTH, 1985 Mutations in the spoT gene of Salmonella typhimurium: effects on his operon expression. J. Bacteriol. 163:534-542
SANDERSON, K. E., A. HESSEL, and K. E. RUDD, 1995 Genetic map of Salmonella typhimurium, edition VIII. Microbiol. Rev. 59:241-303
SCHMIEGER, H., 1972 Phage P22 mutants with increased or decreased transduction activities. Mol. Gen. Genet. 119:75-88[Medline].
SMITH, G. R., 1988 Homologous recombination in procaryotes. Microbiol. Rev. 52:1-28
VINELLA, D., R. D'ARI, A. JAFFÉ, and P. BOULOC, 1992 Penicillin binding protein 2 is dispensable in Escherichia coli when ppGpp synthesis is induced. EMBO J. 11:1493-1501. (erratum: EMBO J. 11: 5137).[Medline].
WILLETTS, N. S. and A. J. CLARK, 1969 Characteristics of some multiply recombination-deficient strains of Escherichia coli. J. Bacteriol. 100:231-239
WILLIAMS, N. L., A. J. HOWELLS, and A. MAXWELL, 2001 Locking the ATP-operated clamp of DNA gyrase: probing the mechanism of strand passage. J. Mol. Biol. 306:969-984[Medline].
ZECHIEDRICH, E. L., A. B. KHODURSKY, S. BACHELLIER, R. SCHNEIDER, and D. CHEN et al., 2000 Roles of topoisomerases in maintaining steady-state DNA supercoiling in Escherichia coli. J. Biol. Chem. 275:8103-8113
This article has been cited by other articles:
![]() |
Z. Pang, R. Chen, D. Manna, and N. P. Higgins A Gyrase Mutant with Low Activity Disrupts Supercoiling at the Replication Terminus J. Bacteriol., November 15, 2005; 187(22): 7773 - 7783. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Kouzminova, E. Rotman, L. Macomber, J. Zhang, and A. Kuzminov RecA-dependent mutants in Escherichia coli reveal strategies to avoid chromosomal fragmentation PNAS, November 16, 2004; 101(46): 16262 - 16267. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |